Acute myeloid leukemia (AML) is a heterogeneous clonal disease associated with a dismal
survival, partly due to the frequent occurrence of relapse. Many patient-and leukemia …

Allogeneic hematopoietic stem-cell transplantation is a potentially curative therapy for
various hematologic diseases. An essential component of this procedure is the pre …

Individuals with acute myeloid leukemia (AML) harboring an internal tandem duplication
(ITD) in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who relapse after …

Background This study compared the effects of pre-transplantation minimal residual disease
(pre-MRD) on outcomes in AML patients who underwent human leukocyte antigen-matched …

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation
(allo-HCT) has a dismal prognosis. We found that T cells of patients relapsing with AML after …

Increasing numbers of patients are receiving allogeneic hematopoietic cell transplantation
(HCT) for acute myeloid leukemia (AML). Scientific and clinical advances in supportive care …

Background The impact of the intensity of conditioning before allogeneic haemopoietic cell
transplantation (HCT) has been studied in a randomised phase 3 trial comparing reduced …

Background Optimal cell type as cell-based therapies for heart failure (HF) remains unclear.
We sought to compare the safety and efficacy of direct intramyocardial transplantation of …

HSCT is a therapeutic procedure that can cure and/or prolong life in a broad range of
hematologic disorders including malignant and nonmalignant pathologies. Conditioning is …

Conditioning regimens play a crucial role in preventing relapse of acute myeloid leukemia
(AML) following allogeneic hematopoietic cell transplantation (HCT). In early times …